EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Discovery of another mechanism for the inhibition of particulate guanylyl cyclases by the natriuretic peptide clearance receptor

Dianxin Liu, Ryan P Ceddia iD, Wei Zhang, Fubiao Shi, Huafeng Fang, Sheila Collins iD

Proceedings of the National Academy of Sciences · 2023

DOI: 10.1073/pnas.2307882120 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, 2023. Verfasst von Dianxin Liu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville TN 37232. Hauptthemen laut MEDLINE: Guanylate Cyclase, Receptors, Atrial Natriuretic Factor. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 64 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDDK NIH HHS, NCI NIH HHS, American Heart Association.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The cardiac natriuretic peptides (NPs) control pivotal physiological actions such as fluid and electrolyte balance, cardiovascular homeostasis, and adipose tissue metabolism by activating their receptor enzymes [natriuretic peptide receptor-A (NPRA) and natriuretic peptide receptor-B (NPRB)]. These receptors are homodimers that generate intracellular cyclic guanosine monophosphate (cGMP). The natriuretic peptide receptor-C (NPRC), nicknamed the clearance receptor, lacks a guanylyl cyclase domain; instead, it can bind the NPs to internalize and degrade them. The conventional paradigm is that by competing for and internalizing NPs, NPRC blunts the ability of NPs to signal through NPRA and NPRB. Here we show another previously unknown mechanism by which NPRC can interfere with the cGMP signaling function of the NP receptors. By forming a heterodimer with monomeric NPRA or NPRB, NPRC can prevent the formation of a functional guanylyl cyclase domain and thereby suppress cGMP production in a cell-autonomous manner.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Guanylate CyclaseReceptors, Atrial Natriuretic FactorReceptors, PeptideNatriuretic PeptidesSignal TransductionAtrial Natriuretic FactorCyclic GMP

Stichwörter der Autor:innen

NPRANPRBNPRCnatriuretic peptidereceptors

Substanzen

Guanylate CyclaseReceptors, Atrial Natriuretic FactorReceptors, PeptideNatriuretic PeptidesAtrial Natriuretic FactorCyclic GMP

Autor:innen und Institutionen

  • Division of Cardiovascular Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville TN 37232.
  • Integrative Metabolism Program, Sanford Burnham Prebys Medical Discovery Institute, Orlando, FL 32827.
  • Department of Molecular Physiology and Biophysics, Vanderbilt University, Nashville, TN 37232.

ORCID-Profile: Ryan P Ceddia, Sheila Collins

Förderung

  • NIDDK NIH HHS
  • NCI NIH HHS
  • American Heart Association
  • HHS | National Institutes of Health
  • American Diabetes Association

Zitieren

APA

Liu, D., Ceddia, R. P., Zhang, W., Shi, F., Fang, H., & Collins, S. (2023). Discovery of another mechanism for the inhibition of particulate guanylyl cyclases by the natriuretic peptide clearance receptor. Proceedings of the National Academy of Sciences. https://doi.org/10.1073/pnas.2307882120

Vancouver

Liu D, Ceddia RP, Zhang W, Shi F, Fang H, Collins S. Discovery of another mechanism for the inhibition of particulate guanylyl cyclases by the natriuretic peptide clearance receptor. Proceedings of the National Academy of Sciences. 2023. doi:10.1073/pnas.2307882120

BibTeX
@article{Liu2023,
  author = {Liu, Dianxin and Ceddia, Ryan P and Zhang, Wei and Shi, Fubiao and Fang, Huafeng and Collins, Sheila},
  title = {Discovery of another mechanism for the inhibition of particulate guanylyl cyclases by the natriuretic peptide clearance receptor},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2023},
  doi = {10.1073/pnas.2307882120}
}
Kostenlos starten →